search
European Medicines Agency
Trends
- 1Global regulators push to replace animal testing in medicine development▼Global regulators call for advancing alternatives to animal testing across the medicine lifecycle
Regulators worldwide, including the European Medicines Agency, have issued a joint call to advance alternatives to animal testing across the entire medicine lifecycle. The initiative urges wider adoption of non-animal methods in drug development, testing and safety assessment. The joint statement signals growing regulatory commitment to reducing and ultimately replacing animal use in pharmaceutical research.
- 2EMA Executive Director speaks at women's health workshop▼Executive Director speech at EMA women’s health multi-stakeholder workshop
The European Medicines Agency's Executive Director delivered a speech at the agency's multi-stakeholder workshop on women's health. The address, published by the EMA, outlines the regulator's position on medicines issues affecting women and the value of bringing together stakeholders from across the sector. The workshop reflects growing regulatory and public attention to women's health as a distinct policy area in Europe.
- 3Women are missing from medicines development, EMA says▼Women are missing from medicines development: EMA’s roadmap for change
The European Medicines Agency has published a roadmap to address the underrepresentation of women in medicines development, from clinical trial participation to research design. The agency says data on how medicines work in women has long been insufficient, and it is setting out measures to improve evidence and health outcomes for female patients across the EU.